NATiAS Inc.

From the company's own site

By combining NATiAS’s proprietary nucleic acid synthesis technology, including Blockmer®, with the management capabilities and global network of the NANO Group, we aim to bring innovative nucleic acid manufacturing technology from Japan to global healthcare. Source (opens in a new tab)

Website

https://natias.co.jp/

Headquarters

JP

Provider types

CDMO, API manufacturer